This finding is in line with epidemiological evidence that APOE ε4 is not only associated with an increased risk of the development of AD but also a lower age of onset (Corder et al., 1993; Rebeck et al., 1993; Farrer et al., 1997; Liu et al., 2013). This evidence concerns the gene APOE and Alzheimer disease.